Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INDP Indaptus Therapeutics, Inc.

休市中 11-22 16:00:00 EST

1.00

-0.04

-4.31%

盘后1.00

+0.000.00%

18:20 EST

最高1.04	最低0.8400	成交量10.26万
今开1.04	昨收1.05	日振幅19.14%
总市值1,020万	流通市值747.70万	总股本1,020万
成交额9.59万	换手率1.37%	流通股本747.70万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INDP","market":"US","secType":"STK","nameCN":"Indaptus Therapeutics, Inc.","latestPrice":1,"timestamp":1732309200000,"preClose":1.045,"halted":0,"volume":102580,"hourTrading":{"tag":"盘后","latestPrice":1,"preClose":1,"latestTime":"18:20 EST","volume":143,"amount":143.525,"timestamp":1732317651555},"delay":0,"floatShares":7477001,"shares":10196884,"eps":-1.707073,"marketStatus":"休市中","marketStatusCode":7,"change":-0.045,"latestTime":"11-22 16:00:00 EST","open":1.04,"high":1.04,"low":0.84,"amount":95905.1768448,"amplitude":0.191388,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.707073,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1438660800000,"adjPreClose":1.045,"preHourTrading":{"tag":"盘前","latestPrice":1.06,"preClose":1.04,"latestTime":"08:40 EST","volume":64,"amount":67.8478976,"timestamp":1732282845019},"postHourTrading":{"tag":"盘后","latestPrice":1,"preClose":1,"latestTime":"18:20 EST","volume":143,"amount":143.525,"timestamp":1732317651555},"volumeRatio":5.245395},"requestUrl":"/m/hq/s/INDP","defaultTab":"news","newsList":[{"id":"2484100676","title":"Indaptus Therapeutics, Inc.盘中异动 快速拉升8.11%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484100676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484100676?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:40","pubTimestamp":1731940825,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时40分，Indaptus Therapeutics, Inc.股票出现异动，股价急速上涨8.11%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为537.61%、294.83%、224.98%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为98.44%、62.38%、42.18%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224025971a72d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224025971a72d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"gpt_icon":0},{"id":"2483640658","title":"Indaptus Therapeutics, Inc.2024财年第三财季实现净利润-3.07百万美元，同比增加21.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483640658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483640658?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:02","pubTimestamp":1731542536,"startTime":"0","endTime":"0","summary":"11月14日，Indaptus Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-3.07百万美元，同比增加21.68%；其中营业收入为0.00美元，每股基本收益为-0.32美元。从资产负债表来看，Indaptus Therapeutics, Inc.总负债2.24百万美元，其中短期债务103982.00美元，资产负债比为3.68，流动比率为3.43。机构评级：截至2024年11月14日，当前有2家机构对Indaptus Therapeutics, Inc.目标价做出预测，其中目标均价为8.50美元，其中最低目标价为5.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a235596f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080224a235596f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","LENZ"],"gpt_icon":0},{"id":"2482381807","title":"Indaptus Therapeutics, Inc.盘中异动 大幅上涨7.56%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482381807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482381807?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:35","pubTimestamp":1731335742,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时35分，Indaptus Therapeutics, Inc.股票出现波动，股价急速上涨7.56%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Revelation Biosciences, Inc.涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为416.73%、147.53%、73.90%，振幅较大的相关个股有天演药业、Windtree Therapeutics, Inc.、Cingulate Inc.，振幅分别为109.34%、109.04%、107.06%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223542a22ce663&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223542a22ce663&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","LENZ","BK4139"],"gpt_icon":0},{"id":"2481022381","title":"Indaptus Therapeutics, Inc.盘中异动 早盘急速拉升9.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481022381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481022381?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:34","pubTimestamp":1731076467,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时34分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升9.66%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Fortrea Holdings Inc.、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为398.37%、17.89%、15.00%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822342795bdef90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822342795bdef90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"gpt_icon":0},{"id":"2481182151","title":"Indaptus Therapeutics, Inc.盘中异动 早盘股价大涨7.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481182151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481182151?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:18","pubTimestamp":1730992739,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时18分，Indaptus Therapeutics, Inc.股票出现波动，股价急速拉升7.76%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Ensysce Biosciences, Inc.、Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为614.84%、125.75%、91.59%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc.、Ensysce Biosciences, Inc.，振幅分别为68.89%、59.31%、57.79%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723185998e413ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723185998e413ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INDP"],"gpt_icon":0},{"id":"2478348675","title":"Indaptus Therapeutics, Inc.盘中异动 股价大跌7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478348675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478348675?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:32","pubTimestamp":1730122376,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时32分，Indaptus Therapeutics, Inc.股票出现异动，股价急速下挫7.41%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213256a1f24daf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213256a1f24daf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"gpt_icon":0},{"id":"2478933571","title":"Indaptus Therapeutics, Inc.盘中异动 早盘急速下跌6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478933571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478933571?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:41","pubTimestamp":1729863684,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时41分，Indaptus Therapeutics, Inc.股票出现异动，股价快速下跌6.71%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214125a1ea8613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025214125a1ea8613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"gpt_icon":0},{"id":"2476499439","title":"Indaptus Therapeutics, Inc.盘中异动 临近收盘快速拉升6.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476499439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476499439?lang=zh_cn&edition=full","pubTime":"2024-10-18 04:00","pubTimestamp":1729195205,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日04时00分，Indaptus Therapeutics, Inc.股票出现异动，股价急速上涨6.29%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Molecular Templates, Inc.、Nkgen Biotech, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Molecular Templates, Inc.、Notable Labs, Ltd.、180 Life Sciences Corp.较为活跃，换手率分别为3472.13%、1473.74%、308.63%，振幅较大的相关个股有Molecular Templates, Inc.、Nkgen Biotech, Inc.、Notable Labs, Ltd.，振幅分别为287.42%、217.10%、152.93%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018040005971a0e82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018040005971a0e82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP","BK4139"],"gpt_icon":0},{"id":"2474209757","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨7.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474209757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474209757?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:11","pubTimestamp":1728655865,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时11分，Indaptus Therapeutics, Inc.股票出现波动，股价急速上涨7.08%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为178.60%、99.81%、18.52%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tc Biopharm  Plc C/Wts 10/02/2028 、Nutriband Inc C/Wts ，振幅分别为57.84%、45.00%、44.64%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112211059719faeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112211059719faeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"gpt_icon":0},{"id":"2472525362","title":"Indaptus Therapeutics, Inc.盘中异动 急速跳水5.93%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472525362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472525362?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:31","pubTimestamp":1727875880,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时31分，Indaptus Therapeutics, Inc.股票出现波动，股价大幅跳水5.93%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Longboard Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为258.25%、13.66%、10.37%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Aditxt, Inc.，振幅分别为145.55%、46.85%、11.25%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213120958bd59f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241002213120958bd59f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139","LENZ"],"gpt_icon":0},{"id":"2470089854","title":"Indaptus Therapeutics, Inc.盘中异动 大幅拉升5.66%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470089854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470089854?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:34","pubTimestamp":1727444072,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时34分，Indaptus Therapeutics, Inc.股票出现波动，股价急速拉升5.66%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Cardio Diagnostics Holdings Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为2139.34%、63.91%、52.21%，振幅较大的相关个股有Chromocell Therapeutics Corporation、Tonix Pharmaceuticals Holding Corp.、Traws Pharma, Inc.，振幅分别为15.00%、12.30%、11.80%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213433ab668293&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213433ab668293&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"gpt_icon":0},{"id":"2459967509","title":"Indaptus Therapeutics, Inc.2024财年第二财季实现净利润-4.02百万美元，同比减少23.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459967509","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459967509?lang=zh_cn&edition=full","pubTime":"2024-08-13 08:00","pubTimestamp":1723507234,"startTime":"0","endTime":"0","summary":"8月13日，Indaptus Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-4.02百万美元，同比减少23.69%；其中营业收入为0.00美元，每股基本收益为-0.47美元。从资产负债表来看，Indaptus Therapeutics, Inc.总负债1.96百万美元，其中短期债务103223.00美元，资产负债比为4.15，流动比率为3.89。机构评级：截至2024年8月13日，当前有2家机构对Indaptus Therapeutics, Inc.目标价做出预测，其中目标均价为10.00美元，其中最低目标价为8.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130800399f259a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130800399f259a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP"],"gpt_icon":0},{"id":"2458519931","title":"Indaptus Therapeutics Inc   预计每股亏损54美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458519931","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458519931?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:54","pubTimestamp":1723222451,"startTime":"0","endTime":"0","summary":"   * Indaptus Therapeutics Inc    预计将于8月12日公布截至2024年6月30日的财报(预计)    *    * LSEG分析师对Indaptus Therapeutics Inc的平均预期是每股亏损54美分。* 华尔街对 Indaptus Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 1.73 美元。8月9日 - 本摘要于北京时间8月9日16:54由机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","INDP"],"gpt_icon":0},{"id":"2457270125","title":"Indaptus Therapeutics, Inc.盘中异动 下午盘大幅跳水5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457270125","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457270125?lang=zh_cn&edition=full","pubTime":"2024-08-06 02:14","pubTimestamp":1722881644,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日02时14分，Indaptus Therapeutics, Inc.股票出现异动，股价快速跳水5.29%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.91%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Cervomed Inc.、木薯科学涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1614.95%、123.08%、44.44%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Alpha Tau Medical Ltd C/Wts 、木薯科学，振幅分别为86.02%、54.22%、44.62%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806021404af95ff16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806021404af95ff16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","INDP","BK4139"],"gpt_icon":0},{"id":"2456873280","title":"Indaptus Therapeutics, Inc.盘中异动 早盘股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456873280","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456873280?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:13","pubTimestamp":1722608021,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时13分，Indaptus Therapeutics, Inc.股票出现异动，股价急速下挫5.85%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。其相关个股中，Os Therapies Incorporated、Dermata Therapeutics, Inc.、Exicure, Inc.涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3240.13%、593.72%、59.57%，振幅较大的相关个股有Os Therapies Incorporated、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Exicure, Inc.，振幅分别为79.69%、60.00%、58.60%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802221341aefcfad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802221341aefcfad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","INDP"],"gpt_icon":0},{"id":"2450443638","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450443638","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450443638?lang=zh_cn&edition=full","pubTime":"2024-07-11 02:33","pubTimestamp":1720636392,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日02时33分，Indaptus Therapeutics, Inc.股票出现波动，股价快速上涨5.19%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为4110.40%、1541.86%、1341.58%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为421.88%、133.16%、130.17%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711023312941f5e19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711023312941f5e19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INDP","BK4139","LENZ"],"gpt_icon":0},{"id":"2444965150","title":"HC Wainwright &amp; Co.：重申Indaptus Therapeutics(INDP.US)评级，由买入调整至买入评级, 目标价由12.","url":"https://stock-news.laohu8.com/highlight/detail?id=2444965150","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444965150?lang=zh_cn&edition=full","pubTime":"2024-06-17 18:40","pubTimestamp":1718620826,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["INDP","BK4139","LENZ"],"gpt_icon":0},{"id":"2441208474","title":"Indaptus Therapeutics, Inc.盘中异动 临近午盘股价大跌5.02%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441208474","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441208474?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:37","pubTimestamp":1717601834,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日23时37分，Indaptus Therapeutics, Inc.股票出现波动，股价急速下挫5.02%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Virios Therapeutics, Inc.、诺瓦瓦克斯医药、Kineta, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Virios Therapeutics, Inc.较为活跃，换手率分别为68.47%、50.73%、46.83%，振幅较大的相关个股有Virios Therapeutics, Inc.、Kineta, Inc.、Biocardia Inc C/Wts 06/08/2024，振幅分别为66.83%、63.28%、41.80%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605233715941ec9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605233715941ec9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","INDP"],"gpt_icon":0},{"id":"2438377587","title":"Indaptus Therapeutics, Inc.盘中异动 股价大涨5.13%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438377587","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438377587?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:30","pubTimestamp":1716903025,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时30分，Indaptus Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Indaptus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Exicure, Inc.、Nutriband Inc C/Wts 、Cytomx Therapeutics, Inc.涨幅较大，Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃，换手率分别为17.18%、7.23%、6.46%，振幅较大的相关个股有Renovorx, Inc.、Novabay Pharmaceuticals, Inc.、Cybin Inc.，振幅分别为7.14%、5.24%、2.78%。Indaptus Therapeutics, Inc.公司简介：Indaptus Therapeutics Inc 是一家临床前生物技术公司，致力于开发一种系统管理的新颖和专利的抗癌和抗病毒免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213026941ea9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213026941ea9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INDP","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.indaptusrx.com","stockEarnings":[{"period":"1week","weight":-0.0711},{"period":"1month","weight":-0.4521},{"period":"3month","weight":-0.3589},{"period":"6month","weight":-0.5534},{"period":"1year","weight":-0.5},{"period":"ytd","weight":-0.4063}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Indaptus Therapeutics, Inc.于2021年2月24日在特拉华州注册成立。这是一个临床阶段的生物制药公司，专注于开发基于它专有的Accordion Pill平台技术。Indaptus的专利技术由单一菌株的减毒和杀灭的非致病性革兰氏阴性细菌组成，具有降低的静脉毒性，但在很大程度上具有激发或激活先天免疫和适应性免疫的许多细胞成分的不妥协能力。这种方法产生了广泛的抗肿瘤和抗病毒活性，包括安全、持久的抗肿瘤反应协同效应与五种不同的现有药物，包括检查点治疗、靶向抗体治疗和临床前模型中的低剂量化疗。通过Indaptus技术根除肿瘤已经证明了先天性和适应性免疫记忆的激活，重要的是，在临床前模型中不需要提供或靶向肿瘤抗原。Indaptus已成功生产了其主要临床候选药物Decoy20的GMP，目前正在完成其他IND使能研究。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.027434},{"month":2,"riseRate":0.444444,"avgChangeRate":0.014519},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.025686},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.016408},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.032542},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.014205},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.050227},{"month":8,"riseRate":0.444444,"avgChangeRate":0.063432},{"month":9,"riseRate":0.4,"avgChangeRate":-0.005204},{"month":10,"riseRate":0.2,"avgChangeRate":-0.111809},{"month":11,"riseRate":0.3,"avgChangeRate":-0.02993},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.047011}],"exchange":"NASDAQ","name":"Indaptus Therapeutics, Inc.","nameEN":"Indaptus Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Indaptus Therapeutics, Inc.(INDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Indaptus Therapeutics, Inc.,INDP,Indaptus Therapeutics, Inc.股票,Indaptus Therapeutics, Inc.股票老虎,Indaptus Therapeutics, Inc.股票老虎国际,Indaptus Therapeutics, Inc.行情,Indaptus Therapeutics, Inc.股票行情,Indaptus Therapeutics, Inc.股价,Indaptus Therapeutics, Inc.股市,Indaptus Therapeutics, Inc.股票价格,Indaptus Therapeutics, Inc.股票交易,Indaptus Therapeutics, Inc.股票购买,Indaptus Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Indaptus Therapeutics, Inc.(INDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Indaptus Therapeutics, Inc.(INDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}